Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer
- PMID: 19908042
- PMCID: PMC11030791
- DOI: 10.1007/s00262-009-0781-9
Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer
Abstract
The human immune system consists of a balance between immune surveillance against non-self antigens and tolerance of self-antigens. CD8(+) T cells and CD4(+) regulatory T cells (Tregs) are the main players for immune surveillance and tolerance, respectively. We examined immunohistochemically the immunological balance at the tumor site using 94 surgically resected colorectal cancer tissues. Forkhead box P3 (FOXP3)(+) cells were considered to be Tregs in the present study. The number of intratumoral FOXP3(+) cells (itFOXP3(+) cells) was positively correlated with lymph node metastases (P = 0.030). itCD8(+) T/itFOXP3(+) cell ratio negatively correlated with pathological stages (P = 0.048). Next, relationship between the number of itCD8(+) T cells or itFOXP3(+) cells and survival prognosis in 94 patients who underwent a curative resection was analyzed. Only itCD8(+) T/itFOXP3(+) cell ratio positively correlated with disease-free survival (0.023) and overall survival (P = 0.010). Multivariate analysis indicated that itCD8(+) T/itFOXP3(+) cell ratio is an independent prognostic factor (P = 0.035) of overall survival. The number of itFOXP3(+) cells positively correlated with transforming growth factor-beta TGF-beta production at the tumor site (P = 0.020). In conclusion, itCD8(+) T/itFOXP3(+) cell ratio is a predictive marker for both disease-free survival time and overall survival time in patients with colorectal cancer. Importantly, itCD8(+) T/itFOXP3(+) cell ratio may be an independent prognostic factor. And, tumor-producing TGF-beta may contribute to the increased number of itFOXP3(+) cells.
Figures



Comment in
-
Risk factors. CD8+:FOXP3+ cell ratio is a novel survival marker for colorectal cancer.Nat Rev Clin Oncol. 2010 Jun;7(6):299. doi: 10.1038/nrclinonc.2010.79. Nat Rev Clin Oncol. 2010. PMID: 20527684 No abstract available.
Similar articles
-
FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.Immunol Res. 2015 Mar;61(3):338-47. doi: 10.1007/s12026-014-8616-y. Immunol Res. 2015. PMID: 25608795 Review.
-
CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.Cancer Med. 2019 Dec;8(17):7330-7344. doi: 10.1002/cam4.2596. Epub 2019 Oct 20. Cancer Med. 2019. PMID: 31631566 Free PMC article.
-
Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.Am J Clin Oncol. 2013 Jun;36(3):224-31. doi: 10.1097/COC.0b013e3182467d90. Am J Clin Oncol. 2013. PMID: 22495453
-
Prognostic value of intra-tumoral CD8+ /FoxP3+ lymphocyte ratio in patients with resected colorectal cancer liver metastasis.J Surg Oncol. 2018 Jul;118(1):68-76. doi: 10.1002/jso.25091. Epub 2018 Jun 7. J Surg Oncol. 2018. PMID: 29878369 Free PMC article.
-
T cell subsets and colorectal cancer: discerning the good from the bad.Cell Immunol. 2012 Sep;279(1):21-4. doi: 10.1016/j.cellimm.2012.08.004. Epub 2012 Sep 14. Cell Immunol. 2012. PMID: 23041206 Review.
Cited by
-
FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.Immunol Res. 2015 Mar;61(3):338-47. doi: 10.1007/s12026-014-8616-y. Immunol Res. 2015. PMID: 25608795 Review.
-
Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastaging.J Gastrointest Surg. 2015 Jun;19(6):999-1006. doi: 10.1007/s11605-015-2759-6. Epub 2015 Mar 26. J Gastrointest Surg. 2015. PMID: 25808375 Free PMC article. Clinical Trial.
-
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.Acta Neuropathol Commun. 2019 Nov 8;7(1):172. doi: 10.1186/s40478-019-0830-3. Acta Neuropathol Commun. 2019. PMID: 31703742 Free PMC article.
-
Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients.Br J Cancer. 2014 Jan 21;110(2):459-68. doi: 10.1038/bjc.2013.696. Epub 2013 Nov 5. Br J Cancer. 2014. PMID: 24196788 Free PMC article.
-
Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer.Fam Cancer. 2011 Sep;10(3):557-65. doi: 10.1007/s10689-011-9449-7. Fam Cancer. 2011. PMID: 21598004
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials